{"id":1067916,"date":"2020-11-05T09:55:52","date_gmt":"2020-11-05T14:55:52","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/catalyst-biosciences-announces-poster-presentation-at-the-62nd-annual-american-society-of-hematology-conference\/"},"modified":"2024-08-18T11:40:52","modified_gmt":"2024-08-18T15:40:52","slug":"catalyst-biosciences-announces-poster-presentation-at-the-62nd-annual-american-society-of-hematology-conference","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/catalyst-biosciences-announces-poster-presentation-at-the-62nd-annual-american-society-of-hematology-conference.php","title":{"rendered":"Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference"},"content":{"rendered":"<p><![CDATA[SOUTH SAN FRANCISCO, Calif., Nov.  05, 2020  (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced a trials in progress poster presentation on Marzeptacog alfa (activated) \u2013 or MarzAA, the Company\u2019s subcutaneously administered next-generation engineered coagulation Factor VIIa (FVIIa), at the upcoming 62nd Annual American Society of Hematology (ASH) meeting being held virtually December 5-8, 2020.]]><\/p>\n<p>View post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/05\/2121131\/0\/en\/Catalyst-Biosciences-Announces-Poster-Presentation-at-the-62nd-Annual-American-Society-of-Hematology-Conference.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference\">Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>View post: Catalyst Biosciences Announces Poster Presentation at the 62nd Annual American Society of Hematology Conference <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/catalyst-biosciences-announces-poster-presentation-at-the-62nd-annual-american-society-of-hematology-conference.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067916","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067916"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067916"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067916\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}